Pedmark® STS
STUDY00006997
Phase 2 small_molecule active
Quick answer
Pedmark® STS for Solid Tumor Malignancies is a Phase 2 program (small_molecule) at FENNEC PHARMACEUTICALS INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- FENNEC PHARMACEUTICALS INC.
- Indication
- Solid Tumor Malignancies
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active